Effect of Antidepressants on White Matter Structure
Status:
Unknown status
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
Subjects with major depression will be evaluated and intensively characterized through
questionnaires, computerized cognitive evaluation and laboratory investigations. Magnetic
resonance imaging will be used to document baseline white matter structure. subjects will
then receive desvenlafaxine which will be adjusted as clinically indicated. After 16 weeks
the evaluations will be repeated.
Phase:
Phase 4
Details
Lead Sponsor:
Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal Centre de recherche Fernand-Seguin, Hôpital Louis-H. Lafontaine